MEDICINES BENEFIT-RISK ASSESSMENT

DESCRIPTION

This course domain covers the Benefit-Risk and Health Economics for Strategic Decision-Making, the Advanced Analytics for Benefit-Risk and Regulatory Decisions, the Health Outcomes and Economic Valuation of Health States and the Quantitative Benefit-Risk Analysis and Decision Modeling.

medicines, benefit-risk assessment

Courses offer
available for this domain

Short Courses

Certificates

Master Year 2

OBJECTIVES

To obtain overview/basic insight into benefit-risk assessment methods (including pharmacoeconomics), the process of decision making on medicines by different stakeholders
To obtain detailed insight into benefit-risk assessment methods (including pharmacoeconomics), the process of decision making on medicines by different stakeholders
To be able to apply benefit-risk assessment methods in daily practice

ACADEMIC SUPERVISION

Prof. Olaf Klungel

Academic domain coordinator
Universiteit Utrecht

ASSOCIATED PARTNERSHIP

Developed with the Pharma Industry expertise of F. Hoffmann-La Roche Ltd, H. Lundbeck A/S, Janssen Pharmaceutica NV, Laboratorios Almirall SA.